PETV

PetVivo Holdings, Inc. to Present at the Life Sciences Investor Forum on June 24th

PetVivo Chief Executive to Present at Life Sciences Forum, Potential PETV visibility boost

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>&lt;link type=&quot;text/css&quot; rel=&quot;stylesheet&quot; href=&quot;https://www.globenewswire.com/styles/gnw_nitf.css&quot;&gt;&lt;/li...</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>PetVivo Holdings announced CEO John Lai will present at the Life Sciences Investor Forum on June 24, 2026, with real-time Q&amp;A and a post-event replay. The update underscores ongoing Spryng with OsteoCushion commercialization, Health Canada recognition, and expanding international distribution, suggesting a near-term catalyst for investor interest and potential partnerships or licensing opportunities.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>PetVivo CEO John Lai to present at Life Sciences Investor Forum on June 24.</li><li>Virtual Investor Conferences hosts the event with live Q&amp;A and replay.</li><li>Company highlights Spryng OsteoCushion, Health Canada recognition, and international distribution.</li><li>1x1 meetings available June 24–30, expanding investor access.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>PetVivo Holdings, Inc. (PETV)</strong>: Primary company issuing the conference notice; potential near-term upside from investor exposure.</li><li><strong>PetVivo Holdings, Inc. (PETVW)</strong>: OTCID listing referenced; provides alternate liquidity channel for investors.</li></ul>
  </section>

  <section data-block="category">
    <h3>Industry News</h3>
    <p>Category: Industry News. Fits as a corporate/market update about investor conference participation and product/regulatory progress that could influence PETV sentiment and liquidity.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Event appearance may lift short-term liquidity and volume as investor interest spikes.</li><li>No revenue guidance provided; market impact depends on management commentary and follow-up deals.</li><li>Health Canada recognition of Spryng may bolster credibility for international expansion.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>PetVivo Holdings, Inc. (PETV, OTCQX) and PETVW (OTCID) announced the forum participation.</li><li>Date: June 24, 2026; Time: 12:00 PM ET.</li><li>1x1 meetings available: June 24–30, 2026.</li><li>Flagship Spryng with OsteoCushion technology targets joint conditions in animals.</li><li>Health Canada recognizes Spryng as a veterinary medical device.</li><li>PetVivo AI initiatives and international distribution efforts cited in highlights.</li><li>PetVivo holds 12 patents and 6 trade secrets.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Near-term PETV upside expected from event exposure; watch for pipeline updates and partnerships over 1–4 weeks.</p>
  </section>
</section>


<article>
  <h2>PetVivo Holdings, Inc. (PETV) Set to Present at Life Sciences Investor Forum on June 24, 2026</h2>

  <p>PetVivo Holdings, Inc. (OTCQX: <strong>PETV</strong>) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI, Inc., today announced that John Lai, Chief Executive Officer of PetVivo Holdings, Inc., will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on June 24th, 2026. The presentation highlights PetVivo’s focus on veterinary medical devices and biomedical therapeutics for equines and companion animals. The event underscores PetVivo’s ongoing investor outreach as it advances its restorative technology portfolio.</p>

  <section>
    <h3>Event Details</h3>
    <ul>
      <li><strong>Date</strong>: June 24th, 2026</li>
      <li><strong>Time</strong>: <strong>12:00pm ET</strong></li>
      <li><strong>Format</strong>: Live presentation conducted online via VirtualInvestorConferences.com</li>
      <li><strong>1x1 Meetings</strong> availability: June 24, 2026, through June 30, 2026</li>
      <li><strong>Registration</strong>: <a href="https://www.globenewswire.com/Tracker?data=DETa5OeaP9q2D2Cx5IWEqT5eOpP_Tnoyp68Ieb-omEFWPR5j6yCrzspyIyPItEQuq4pA5v_tY5wYYbydo263UDZZcPYHD9CfOf8XwPfu-4meOdpX3zD_67Ai33GbxG4xaBioGdDP58wYF1pBfx-xNtsO5E_Jnl5rXkpJ9F93rOwv22bO1AQcnyYWnn5tno3YQIhC5wC5nu3PtuWZ6zvFhFtfCh0_nDBW61dcdOU0QkFL5FKX68grjlYid_FaATRFazltqz82LTr4ntZfQiJK2w==" rel="nofollow" target="_blank"><strong>REGISTER HERE</strong></a></li>
    </ul>

    <p>The online forum will enable investors and life sciences professionals to submit questions to management in real time, with a replay of the webcast available after the conference concludes. Online attendees are encouraged to pre-register and run the online system check to expedite participation and receive event updates.</p>
  </section>

  <section>
    <h3>Participation Details and Scheduling</h3>
    <p>Available for 1x1 meetings: June 24, 2026, through June 30, 2026. Schedule 1x1 Meetings <a href="https://www.globenewswire.com/Tracker?data=z3qOYWxoyEYJiQkZlCfNtWecyX5FlBKzjvXg07OZtIYnOMxTDaZ8Je07ceK3HGUwtcmFmHSfbwmeAh_LPZGmkrQqyvwB4FLTEFmv7Khii-3kSug3GLxIp76DPVC5SGtt7jUGcYinJX4K8SGENevA0FiNS1SiF2qXQFhD6N7ERYXbYMD5XGKGDMYmUnmCH7dwjrqq9ZVnVXWqY8WA_LrANw==" rel="nofollow" target="_blank">here</a>.</p>

    <p>The event will be conducted as a <em>live, interactive online forum</em>, offering investors and industry professionals within the life sciences community the opportunity to submit questions to management in real time. A replay of the webcast will be available following the conclusion of the conference.</p>
  </section>

  <section>
    <h3>Context and Company Highlights</h3>
    <p><strong>Recent Company Highlights</strong><br/>PetVivo Holdings, Inc. is a veterinary medical technology company focused on improving the quality of life for companion animals through innovative medical device and other therapeutic solutions. Its flagship product, Spryng<sup>®</sup> with OsteoCushion<sup>®</sup> Technology, is a veterinarian-administered, intra-articular injection composed of biocompatible collagen-elastin microparticles designed to restore proper joint mechanics and assist in the management of lameness, osteoarthritis, and other joint-related conditions in dogs, cats, and horses. Unlike traditional therapies that primarily address symptoms, Spryng helps provide structural support within the joint and has demonstrated favorable clinical outcomes and safety profiles across multiple studies.</p>

    <p>Recent highlights for PetVivo include continued expansion of Spryng commercialization efforts, growing clinical evidence supporting the product's safety and efficacy, the advancement of international distribution initiatives, Health Canada recognition of Spryng as a veterinary medical device, the launch and development of PetVivo AI initiatives, and ongoing collaborations to expand the Company’s restorative technology and biomaterials portfolio for both animal and future human healthcare applications. The Company continues to leverage its proprietary technology platform, intellectual property portfolio, distributor relationships, and commercialization infrastructure to drive growth and expand market adoption.</p>
  </section>

  <section>
    <h3>About PetVivo Holdings, Inc.</h3>
    <p>PetVivo Holdings Inc. (OTCQX:<a href="https://www.benzinga.com/quote/PETV">PETV</a>, OTCID: PETVW), in cooperation with its wholly owned subsidiaries PetVivo Animal Health, Inc. and PetVivo AI Inc., is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The Company’s strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics.</p>

    <p>PetVivo has a robust pipeline of products for the treatment of animals and people. A portfolio of twelve patents and six trade secrets protect the Company’s biomaterials, products, production processes and methods of use. The Company's lead products SPRYNG<sup>®</sup> with OsteoCushion<sup>®</sup> technology, a veterinarian-administered, intra-articular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses, and PrecisePRP<sup>®</sup>, a first-in-class, off-the-shelf, platelet-rich plasma (PRP) product designed for use by veterinarians, are currently available for commercial sale.</p>
  </section>

  <section>
    <h3>About Virtual Investor Conferences</h3>
    <p>Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. The service delivers real-time investor engagement solutions designed to offer companies more efficient investor access, including the ability to connect with investors, schedule targeted one-on-one meetings, and enhance presentations with dynamic video content. VIC serves a global network of retail and institutional investors.</p>
  </section>

  <section>
    <h3>Contacts</h3>
    <p><strong>PetVivo Holdings, Inc.</strong><br/>John Lai<br/>Chief Executive Officer<br/><a href="https://www.globenewswire.com/Tracker?data=daFGDDeJA1o2gWoZ5UWuGPi-NOB756FGX5xyj6IGUOucMxffT0Lzmy1R3-FisWIJCKShSiuFxFATQxy15KxskE_WiimJp9wuBKW1sD4SFLQ=" rel="nofollow" target="_blank">Email Contact</a><br/>Tel (952) 405-6216</p>

    <p><strong>Virtual Investor Conferences</strong><br/>Greg Young<br/>VP Corporate Services, Investor Access<br/>OTC Markets Group<br/>(212) 652-5958<br/><a href="https://www.globenewswire.com/Tracker?data=me90Kw7ruC-ruHZpCY03q7Hbzl0aCgSvXC7-ORBSYFAd2j8Uus3sFTesmo12Xbc5Lqphkw8QZqoVjZV1eP6bj5imWMTjOy4tXRCUcH8S0W8S0=" rel="nofollow" target="_blank">greg@otcmarkets.com</a></p>
  </section>
</article>

PetVivo Holdings announced CEO John Lai will present at the Life Sciences Investor Forum on June 24, 2026, with real-time Q&A and a post-event replay. The update underscores ongoing Spryng with OsteoCushion commercialization, Health Canada recognition, and expanding international distribution, suggesting a near-term catalyst for investor interest and potential partnerships or licensing opportunities.

PetVivo Holdings, Inc. to Present at the Life Sciences Investor Forum on June 24th

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Industry News

Related News